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1. Introduction 
Diabetes mellitus is a chronic illness which has an outstanding impact on public health 
due to its increasing prevalence, poor prognosis, and due to the high impact on 
cardiovascular health. Such is its importance, that diabetes is actually considered an 
independent predictor of cardiovascular disease (which includes coronary heart disease 
and stroke). Moreover, the cardiovascular risk of individuals with diabetes is considered 
to be equivalent to the risk of nondiabetic individuals with pre-existing cardiovascular 
diesease. Therefore, persons with diabetes mellitus have an increased susceptibility to 
atherosclerosis and an increased prevalence of ahterogenic risk factors, notably 
hypertension, obesity, and anormal lipids. This compendium of the abnormalities can be 
found in people with metabolic syndrome (MetS) which is now regarded as a prelude to 
diabetes and such as diabetes, MetS is a substantial predictor of cardiovascular disease 
and all-cause mortality(Ford, et al. 2002). 
Morbidity and mortality from these chronic diseases in the general population have a 
multifactorial origin, resulting from the interaction between genetic background and 
environmental factors. Among the latter, diet is probably the most relevant factor in order to 
prevent acute complications and to reduce the risk of long-term complications. Thus, it has 
been demonstrated that medical nutrition therapy is important in preventing diabetes, 
managing existing diabetes, and preventing, or at least slowing, the rate of development of 
diabetes complications. The basis of what constitutes optimal nutrition has been the subject 
of decades of research spanning the whole range of study designs, from ecological studies to 
in vitro modulation of gene expression. Based on this approach, there is now sufficient 
evidence supporting the notion that the monounsaturated fatty acids (MUFA) as a nutrient, 
olive oil as a food, and the Mediterranean diet (MedDiet) as a food pattern are associated 
with a decreased risk of cardiovascular disease, MetS, and diabetes mellitus. 
 In the last decade, research in nutritional epidemiology has moved from the single food 
approach to the dietary pattern, which better reflects the complexity of interactive effects of 
multiple nutrients on health status(Hu 2002; Trichopoulou, et al. 2003; Trichopoulou, et al. 
1995). Thus, the MedDiet pattern is built on the basis of a consumption of fat primarily from 
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foods high in MUFA (olive oil as the principal source of fat), and emphasizes the 
consumption of fruits, vegetables, legumes, nuts, and fish, as well as a moderate 
consumption of alcohol. In this regard, the MedDiet pattern has been associated with higher 
survival due to lower all cause mortality(Knoops, et al. 2004). A recent meta-analysis of 
prospective studies based on 1.5 million subjects and 40,000 fatal and non-fatal events 
showed that a greater adherence to this dietary pattern was significantly associated with a 
reduction of overall mortality, cardiovascular mortality, cancer incidence and cancer 
mortality, and incidence of Alzheimer’s disease and Parkinson’s disease(Sofi, et al. 2008). In 
addition, a recently cross-sectional assessment of baseline data from a cohort of high-risk 
participants in the PREDIMED study, a large-scale feeding trial of primary cardiovascular 
prevention(Sanchez-Tainta, et al. 2008), showed that adherence to the MedDiet was 
inversely associated with the clustering of diabetes mellitus, obesity, hypertension and 
hypercholesterolemia. The follow-up of large cohorts of healthy populations living in 
Mediterranean countries, such as the Greek EPIC(Psaltopoulou, et al. 2004; Trichopoulou, et 
al. 2005a; Trichopoulou et al. 2003; Trichopoulou, et al. 2005b) and ATTICA(Panagiotakos, et 
al. 2009a; Panagiotakos, et al. 2006) study cohorts and the Spanish EPIC(Agudo, et al. 2007) 
and SUN(Nunez-Cordoba, et al. 2009) study cohorts, are providing new information 
suggesting that increasing adherence to the MedDiet relates to a reduced prevalence of risk 
phenotypes. In this regard, the MedDiet pattern is being reconsidered as the one of the more 
holistic approaches for the control of metabolic diseases including at the same time salutary 
and pleasure components.  
The principal goals of medical nutrition therapy for subjects with metabolic syndrome, 
and/or diabetes are to attain and maintain an optimal metabolic control, including blood 
glucose, lipid profiles, and blood pressure; to prevent and treat obesity and cardiovascular 
complications; and to improve general health and well-being through food choices that take 
personal and cultural preferences into consideration. In this regard, pioneering nutritional 
strategies, such as nutraceuticals, have been developed aimed at reducing the main 
metabolic risk factors and promoting cardiovascular health. In this context, a growing body 
of clinical evidence has demonstrated positive cardiovascular effects associated with olive 
oil, antioxidants, and polyphenols intake.  
Traditionally, many beneficial properties associated with olive oil have been ascribed to its 
high oleic acid content. Olive oil, however, can be considered a functional food that, besides 
having high-MUFA content, contains other minor components with biological 
properties(Perez-Jimenez, et al. 2007). Thus, phenolic compounds have shown antioxidant 
and antiinflammatory properties, prevent lipoperoxidation, induce favorable changes of 
lipid profile, improve endothelial function, and disclose antithrombotic properties(Lopez-
Miranda, et al. 2007; Lopez-Miranda, et al. 2010; Perez-Jimenez, et al. 2005; Perez-Jimenez, et 
al. 2006; Ruano, et al. 2007; Ruano, et al. 2005). Therefore, all those evidences suggest that 
MedDiet could serve as an antiinflammatory dietary pattern, which could help fighting 
diseases that are related to chronic inflammation, such as MetS and type 2 diabetes. In this 
context, it has been clearly demonstrated that many components of the MedDiet have been 
considered to be important in the treatment and modulation of cardiometabolic diseases. In 
the present chapter, we review the state of the art illustrating the relationship between 
MedDiet rich in olive oil and metabolic diseases, including MetS and diabetes mellitus and 
to discuss potential mechanisms by which this food can help in disease prevention and 
treatment. 
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2. Mediterranean diet and diabetes 
In the last decade the incidence of conditions associated with insulin resistance, including 
metabolic syndrome and diabetes mellitus, is increasing rapidly worldwide. Although 
pharmacological interventions are available for minimizing or delaying the comorbidities 
associated with insulin resistance and the metabolic syndrome, as well as diabetes, initial 
management for the vast majority of the affected population remains focused on lifestyle 
modification, consisting of sustainable changes in dietary habits and physical activity. 
Lifestyle modification, in particular recommendations to follow an appropriate dietary 
pattern, has generally been accepted as a cornerstone of treatment for people with these 
conditions, with the expectation that an appropriate intake of energy and nutrients will 
improve glycaemic control and will reduce the risk of complications. The factors that 
regulate body fat distribution, insulin resistance, and associated metabolic disturbances are 
not fully understood. Nevertheless, increasing scientific evidence suggests that dietary 
habits may be an important environmental factor regulating glucose and fat 
metabolism(Phillips, et al. 2006). Epidemiological studies indicate that Western-style dietary 
patterns promote the MetS, while diets rich in vegetables, fruits, grains, fish and low-fat 
dairy products have a protective role(Esmaillzadeh, et al. 2007; Lutsey, et al. 2008; Pereira, et 
al. 2005). In the same line, two studies in Southern European populations showed that a 
greater adherence to the MedDiet was associated with reduced prevalence (Panagiotakos, et 
al. 2004)  and incidence (Tortosa, et al. 2007) of MetS. To date, several feeding trials have 
assessed the effect of dietary patterns on the metabolic syndrome status (Azadbakht, et al. 
2005; Esposito, et al. 2004; Orchard, et al. 2005; Salas-Salvado, et al. 2008). These studies used 
a behavioral program to implement a relatively low-fat MedDiet(Esposito et al. 2004), 
intensive lifestyle intervention with inclusion of a vegetable-rich diet restricted in animal fat 
(Orchard et al. 2005), the DASH diet (Azadbakht et al. 2005), and two MedDiets 
supplemented with virgin olive oil or nuts(Salas-Salvado et al. 2008) in comparison with 
standard advices. Three studies (Azadbakht et al. 2005; Esposito et al. 2004; Orchard et al. 
2005) used energy-restricted diets that led to some degree of weight loss, while one 
study(Salas-Salvado et al. 2008) used ad libitum diets. In all these studies, a decreased 
prevalence of metabolic syndrome was shown in the intervention groups. In the PREDIMED 
study(Salas-Salvado et al. 2008), the MedDiet with nuts significantly reduced MetS 
prevalence at 1 year, mostly because of increased reversion of prior MetS due to reduction in 
waist girth in spite of no weight loss, suggesting fat redistribution. Moreover, in a subgroup 
of this study including the Reus PREDIMED Centre some components of the MedDiet, such 
as olive oil, legumes and red wine were associated with lower prevalence of MetS (Babio, et 
al. 2009). On the other hand, results of a study in overweight, insulin-resistant patients also 
suggest that, by comparison with a low-fat diet, a MUFA-rich diet prevents the 
redistribution of body fat from peripheral to visceral adipose tissue without affecting total 
body weight(Paniagua, et al. 2007b). More recently Jimenez-Gomez et al. have demonstrated 
that postprandial abnormalities associated with MetS can be attenuated with high MUFA 
diets(Jimenez-Gomez, et al. 2010). 
Because diabetes is a frequent outcome in patients with sustained MetS, it is reasonable to 
assume that the MedDiet might also prevent the development of diabetes in predisposed 
persons or beneficially influence the metabolic abnormalities associated with the diabetic 
status(Giugliano and Esposito 2008). In this context, two prospective studies from 
Southern European cohorts suggest a lower incidence of diabetes with increasing 
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adherence to the MedDiet in previously healthy persons(Martinez-Gonzalez, et al. 2008) 
or survivors of a myocardial infarction(Mozaffarian, et al. 2007). In contrast, in the 
absence of weight loss, the low-fat diet used in the Women’s Health Initiative trial(Tinker, 
et al. 2008) was ineffective to prevent the development of diabetes. Furthermore, in the set 
of the PREDIMED study, it has been tested the effects of two MedDiet interventions 
versus a low-fat diet on incidence of diabetes. This was a three-arm randomized trial in 
418 nondiabetic subjects aged 55–80 years where participants were randomly assigned to 
education on a low-fat diet (control group) or to one of two MedDiets, supplemented with 
either free virgin olive oil (1 liter/week) or nuts (30 g/day). Diets were ad libitum, and no 
advice on physical activity was given. After a median follow-up of 4.0 years, diabetes 
incidence was 10.1%, 11.0%, and 17.9% in the MedDiet with olive oil group, the MedDiet 
with nuts group, and the control group, respectively. Multivariable adjusted hazard ratios 
of diabetes were 0.49 (0.25– 0.97) and 0.48 (0.24–0.96) in the MedDiet supplemented with 
olive oil and nuts groups, respectively, compared with the control group. Interestingly, 
when the two MedDiet groups were pooled and compared with the control group, 
diabetes incidence was reduced by 52%. In all study arms, increased adherence to the 
MedDiet was inversely associated with diabetes incidence. It is also important to highlight 
that diabetes risk reduction occurred in the absence of significant changes in body weight 
or physical activity. These results extend those of prior studies showing that lifestyle 
interventions can substantially reduce the incidence of diabetes in individuals at high 
risk(Knowler, et al. 2002; Pan, et al. 1997; Ramachandran, et al. 2006; Tuomilehto, et al. 
2001). However, in these studies, the interventions consisted of advice on a calorie-
restricted diet plus physical activity and, except for one study(Ramachandran et al. 2006), 
weight loss was a major driving force in reducing the incidence of diabetes(Salas-Salvado, 
et al. 2011). 
Diets high in SFA consistently impair both insulin sensitivity and blood lipids, while 
substituting carbohydrates or MUFA for SFA reverts these abnormalities(Riccardi, et al. 
2004). Postprandial lipemia and glucose homeostasis are also improved after meals 
containing MUFA from olive oil compared to meals rich in SFA(Lopez, et al. 2008; Paniagua, 
et al. 2007a). Thus, an examination of the association of dietary and membrane fatty acids 
with insulin secretion in the cross-sectional Pizarra study(Rojo-Martinez, et al. 2006) showed 
that dietary MUFA contributed to the variability of ǃ-cell function, with a favorable 
relationship of MUFA with ǃ-cell insulin secretion, independently of the level of insulin 
resistance. 
The question as to what was the best nutrient to replace energy sources from SFA in the 
diabetic diet, carbohydrates or MUFA, was also hotly debated. Since the late 1980’s, many 
feeding trials have compared the effects of isoenergetic high carbohydrates (CHO) and high 
MUFA diets on insulin sensitivity in healthy subjects and on glycemic and lipid control in 
diabetic patients(Garg 1998; Ros 2003). Garg’s meta-analysis(Garg 1998) favored high MUFA 
diets, but most of the studies reviewed therein were performed with metabolic diets having 
wide differences in total fat content between the two experimental diets, ranging from 15% 
to 25% of energy. The studies reviewed by Ros(Ros 2003) were performed on an outpatient 
basis with natural foods, olive oil as the main source of MUFA, and <15% energy difference 
in total fat content between diets; the conclusion was that both dietary approaches provided 
a similar degree of glycemic control. Nevertheless, high MUFA diets generally had more 
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favorable effects on proatherogenic alterations associated with the diabetic status, such as 
dyslipidemia, postprandial lipemia, small LDL, lipoprotein oxidation, inflammation, 
thrombosis, and endothelial dysfunction(Ros 2003). Although we will discuss this point 
later, of particular interest is the ability of the olive oil-rich MedDiet to improve mild 
systemic inflammation, as shown by the reduction of C-reactive protein and inflammatory 
cytokines in the study of Esposito et al.(Esposito et al. 2004) in subjects with MetS and by the 
PREDIMED study(Estruch, et al. 2006) in diabetic patients and other subjects at high risk for 
coronary heart disease (CHD). In addition, in a cross-sectional analysis of a population of 
type 2 diabetic patients, the adherence to a MedDiet was inversely associated with 
glycosylated haemoglobin and postprandial glucose levels during free living conditions, 
independent of age, adiposity, energy intake, physical activity and other potential 
confounders(Esposito, et al. 2009b). This association was apparent even although no strong 
associations were evident for each of the components of the MedDiet score, except for a 
modest association with whole grains and the ratio of MUFA to saturated lipids. However 
its cross-sectional nature does not allow us to make inference about cause and effect. 
According to these findings, Itsiopoulos et al. have recently demonstrated that a traditional 
MedDiet improved glycemic control, glycosylated haemoglobin fell from 7.1% to 6.8%, in 
men and women with well-controlled type 2 diabetes, without adverse effects on 
weight(Itsiopoulos, et al. 2010). Furthermore a systematic review of the available studies 
confirmed that adopting a MedDiet may help to prevent type 2 diabetes, and also improve 
glycaemic control and cardiovascular risk in persons with established diabetes(Esposito, et 
al. 2010). 
Despite the beneficial effect attributed to the MedDiet, the American Diabetes Association 
(ADA) recommends that patients with newly diagnosed type 2 diabetes be treated with 
pharmacotherapy as well as lifestyle changes(Nathan, et al. 2006). The rationale for 
combination therapy is presumably that each form of treatment alone is imperfect. Lifestyle 
changes are often inadequate because patients do not lose weight or regain weight or their 
diabetes worsens independent of weight. Pharmacotherapy also often fails with 
time(Turner, et al. 1999), and some drugs have associated cardiovascular and other 
risks(Goldfine 2008). In this context Esposito et al. in 2009, conducted a randomized trial to 
compare the effects of a low-carbohydrate Mediterranean-style or a low-fat diet on the need 
for antihyperglycemic drug therapy in 215 patients with newly diagnosed type 2 
diabetes(Esposito, et al. 2009a). After 4 years, they found that the MedDiet delayed the need 
for antihyperglycemic drug therapy. There were no differences in the degree to which 
participants in each group increased their physical activity or decreased their caloric intake, 
so the effect seems specific to the MedDiet and is probably, although not exclusively, linked 
to its ability to induce greater weight loss, in accord with results of a recent trial(Shai, et al. 
2008). The between-group difference in the proportion of people needing antihyperglycemic 
drug therapy increased over the course of the trial and favored the MedDiet, whereas the 
between-group differences in weight loss decreased. Consumption of MUFA is thought to 
increase insulin sensitivity(Due, et al. 2008; Esposito et al. 2004; Shai et al. 2008), and this 
component of the diet might explain the favorable effect of the MedDiet on the need for 
drug therapy. In summary, although more data are mandatory, there is good scientific 
support for MedDiet diets, especially those based on olive oil, as an alternative approach to 
low-fat diets for the medical nutritional therapy in MetS and diabetes. 
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3. Protective mechanisms of mediterranean diet  
Several mechanistic links offer potential explanations of protective effect of the MedDiet on 
type 2 diabetes. Excessive oxidative stress and inflammation are closely associated with the 
pathogenesis of many human diseases (such obesity, MetS, diabetes, cardiovascular 
diseases, neurodegenerative diseases and aging). The potential reversal of those conditions 
can be achieved by reducing the levels of inflammation through the consumption of an anti-
inflammatory dietary pattern. Usually this may occur through the reduction of systemic 
vascular inflammation and endothelium dysfunction without having a drastic effect on 
body weight. Phenolic compounds are the focus of intense research in the last years, due to 
the biological properties that they have proven, mainly as potent antioxidants and anti-
inflammatory agents; therefore, they can modulate signal transduction pathways to elicit 
their beneficial effects in human diseases. These mechanisms include modulation of pro-
inflammatory gene expression such as cyclooxygenase, lipoxygenase, nitric oxide synthases 
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Fig. 1. Health effects of the Mediterranean Diet rich in olive and the potential mechanisms 
by which this diet can help in disease prevention and treatment. 
www.intechopen.com
 
Nutritional Therapy in Diabetes: Mediterranean Diet 
 
397 
and several pivotal cytokines, mainly by acting through NF-ĸb and mitogen-activated 
protein kinase signaling. It is of note that phenols are not uniquely represented in olive oil in 
the traditional MedDiet, but also in other classic foods, such as wine, fruits and vegetables. 
Beyond this, epidemiological and interventional studies have revealed a protective effect of 
the MedDiet against mild chronic inflammation and its metabolic complications 
(Chrysohoou, et al. 2004; Dai, et al. 2008; Panagiotakos, et al. 2009b).  
3.1 Inflammation and oxidative stress 
The origins of heightened inflammatory activity in diabetes are diverse. In type 1 diabetes, 
islet inflammation is thought to be a local phenomenon driven by a focal autoimmune attack 
on islet antigens. By contrast, in type 2 diabetes, activation of inflammation results from 
systemic etiologic factors, such as central obesity and insulin resistance. Ultimately 
inflammatory mediators activate a series of receptors and transcription factors such as NF-
ĸb, toll-like receptors, c-Jun amino terminal kinase, and the receptor for advanced glycation 
end products, which lead to ǃ-cell dysfunction and apoptosis, impaired insulin signaling in 
insulin-sensitive tissues, systemic endothelial dysfunction, and altered vascular flow. In this 
context inflammation at the cellular level can be described as an increase in the NF-κB in the 
nucleus and with a concomitant decrease in its inhibitors IκB-alpha and/or IκB-
beta(Ghanim, et al. 2004). NF-κB is a pleiotropic transcription factor activated by low levels 
of reactive oxygen species (ROS) and inhibited by antioxidants(Mantena and Katiyar 2006). 
This factor regulates the expression of several cytokines, chemokines, cell adhesion 
molecules, immunoreceptors and inflammatory enzymes(Piva, et al. 2006), molecules that 
are involved in disease such as atherosclerosis and insulin resistance. In most cells, NF-κB 
(p50/p65) is present in an inactive form in the cytoplasm, bound to an inhibitor IκB. Certain 
stimuli result in the phosphorylation, ubiquitination and subsequent degradation of IκB 
proteins thereby enabling translocation of this transcription factor into the nucleus. In this 
context, an interesting aspect was the demonstration that supplementing an endothelial cell 
culture with oleic acid reduces the transcriptional activation of this factor in these cells, 
similar to what is done by ǂ-linolenic acid, and the opposite of the inflammatory effect of 
linoleic acid. Hennig et al.(Hennig, et al. 2000) exposed porcine endothelial cells to 18-carbon 
fatty acids. Both linoleic and stearic fatty acids activated endothelial cells more markedly 
than did either oleic or linolenic fatty acids. Also, compared with control cultures, treatment 
with stearic and linoleic acids decreased glutathione concentrations, which suggested an 
increase in cellular oxidative stress. This increase in oxidative stress with the subsequent 
activation of NF-κB could be one of the mechanisms of the inflammatory properties of 18:0 
and 18:2 fatty acids. Previous studies have confirmed that fat consumption induced the 
activation of inflammatory markers(Jellema, et al. 2004). In this regard, Bellido and Perez-
Martinez have previously demonstrated that the MedDiet, enriched in virgin olive oil, 
attenuated peripheral blood mononuclear cells (PBMCs) NF-κB activation compared with a 
Western SFA rich diet, and the effect of an n-3 PUFA-enriched diet was intermediate in 
young healthy population(Bellido, et al. 2004; Perez-Martinez, et al. 2007). These findings 
suggest that virgin olive oil could be a possible contributor to prevent the activation of NF-
κB system, within the frame of the MedDiet. Besides olive oil, the MedDiet contents other 
source of potentially cardioprotective nutrients from fruits and vegetables which could also 
enhance this beneficial effect. In contrast, the opposite effect has been observed after the 
chronic intake of a Western diet rich in saturated fatty acids, corroborating previous data 
www.intechopen.com
Recent Advances in the Pathogenesis, Prevention and  
Management of Type 2 Diabetes and its Complications 
 
398 
after the acute intake of a butter meal. The effect of a high CHO diet enriched in n-3 fatty 
acids on the NF-κB activation was intermediate. In this sense, previous data have suggested 
that n-3 ǂ-linolenic acid found mainly in plants and walnuts may reduce cardiovascular risk 
through a variety of biological mechanisms, including inhibiting vascular inflammation.  
In the same context, Brunelleschi et al.(Brunelleschi, et al. 2007) explored the effects of an 
extra-virgin olive oil extract, particularly rich in minor polar compounds, on NF-κB 
translocation in monocytes and monocyte-derived macrophages isolated from healthy 
volunteers. In a concentration-dependent manner, olive oil extract inhibited p50 and p65 
NF-κB translocation in both un-stimulated and phorbol-myristate acetate challenged cells, 
being particularly effective on the p50 subunit. Interestingly, this effect occurred at 
concentrations found in human plasma after nutritional ingestion of virgin olive oil and was 
quantitatively similar to the effect exerted by ciglitazone, a PPAR-Ǆ ligand. However, olive 
oil extract did not affect PPAR-Ǆ expression in monocytes and monocye-derived 
macrophages(Brunelleschi et al. 2007). These data suggest the hypothesis of a protective 
effect of extra-virgin olive oil by indicating its ability to inhibit NF-κB activation in human 
monocyte/macrophages. On the other hand, NF-κB has been shown to regulate the 
expression of several adhesion molecules in response to inflammatory stimuli, including P-
selectin, E-selectin, intercellular adhesion molecule 1 (ICAM-1) and cell adhesion molecule 
1(VCAM-1)(Ghosh, et al. 1998), all implicated in atherosclerosis development. Carluccio et 
al.(Carluccio, et al. 1999) observed, in an endothelial cell culture model, that the 
incorporation of oleic acid into cellular membrane lipids reduced the expression of VCAM-
1. Furthermore, it has been observed that the expression of VCAM-1 and E-selectin in 
human umbilical vascular endothelial cells (HUVECs), following the addition of minimally 
oxidised LDL, was less with LDL obtained from persons who had followed a diet rich in 
olive oil than from persons whose diet was rich in saturated fat(Bellido, et al. 2006). This 
anti-inflammatory action of MUFA also explains the fact that the enrichment of LDL 
particles with oleic acid, during the consumption of different types of diet, reduces their 
capacity to induce monocyte chemotaxis and adhesion. In accordance with these results, a 
previous study has shown that LDL obtained from a MUFA-rich diet induced a lower rate 
of monocyte adhesion to endothelial cells(Mata, et al. 1996).  
The mechanism by which LDL from carbohydrate and MedDiets induces a lower expression 
of VCAM-1 and E-selectin is unknown; however several hypotheses have been suggested, 
for instance, the interaction of mononuclear leukocytes with vascular endothelial cells is 
most likely mediated by a complex amalgam of interacting regulatory signals in the 
inflammatory response characteristic of early atherogenesis. In another study including 
healthy subjects, virgin olive oil reduced plasma levels of ICAM-1(Bellido et al. 2004). This 
anti-inflammatory effect has also been observed in MetS patients who modified their diet 
for two years. In the group that followed a MedDiet model, the prevalence of this 
syndrome was reduced, improved insulin sensitivity and lowered the levels of C-reactive 
protein (CRP) and interleukin 6, 7 and 18. Such findings have recently been corroborated 
by Estruch et al.(Estruch et al. 2006) who evaluated the short-term effects of two ad 
libitum MedDiets (supplemented with either 1 l/week of virgin olive oil or 30 g/day of 
nuts) and an ad libitum low-fat diet on intermediate markers of cardiovascular disease. 
Compared with participants in the low-fat group, after 3 months those in the MedDiet 
groups had decreased levels of C-reactive protein. In addition, olive oil consumption also 
reduced levels of IL-6, VCAM-1 and ICAM-1. Moreover, people who eat the MedDiet that 
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includes virgin olive oil reduce their levels of oxidized LDL, as suggested by the results of 
a subgroup analysis of the PREDIMED study carried out in 372 participants at high risk 
for cardiovascular disease, including diabetes(Fito, et al. 2007). Furthermore new data 
suggest that virgin olive oil intake was associated with higher levels of plasma 
antioxidant capacity after 3 years of intervention(Razquin, et al. 2009). In summary, based 
in the above evidences presented, we could assume that the MedDiet rich in nutrients 
with favorable anti-inflammatory properties may protect from metabolic diseases that are 
related to chronic inflammation and overproduction of reactive oxygen species, such as 
MetS and diabetes.  
3.2 Postprandial state 
When explaining possible mechanisms is important to recall that fasting is not the typical 
physiological state of the modern human being, which spends most the time in the 
postprandial state. Therefore, the assessment of the postprandial lipemic response may be 
more relevant to identify disturbances in metabolic pathways related to inflammation and 
oxidative stress than measures taken in the fasting state. With regard to the postprandial 
state, several previous studies have demonstrated that a breakfast enriched in saturated fat 
resulted in an increase in biomarkers of inflammation and oxidative stress(Cardona, et al. 
2008; Devaraj, et al. 2008; Ursini, et al. 1998). In this regard, the identification of increased 
expression of TNF-ǂ, a proinflammatory cytokine, in the adipose tissue of obese mice and 
humans has been correlated with the degree of adiposity and associated with insulin 
resistance. This fact is crucial given than insulin resistance will drive towards an increase in 
oxidative stress, endothelial dysfunction and impairments in lipoprotein metabolism and 
blood pressure. Therefore, targeting TNF-ǂ and/or its receptors has been suggested as a 
promising treatment for insulin resistance and type 2 diabetes(Tzanavari, et al. 2010). In this 
scenario Jimenez-Gomez et al. observed that a breakfast rich in olive oil or walnuts 
decreased postprandial expression of mRNA TNF-ǂ in PBMCs from healthy men compared 
with a butter-enriched breakfast(Jimenez-Gomez, et al. 2009). However, the effects of the 
three fatty breakfasts on the plasma concentrations of these proinflammatory parameters 
showed no significant differences. The fact that we only found differences in the expression 
of TNF-ǂ at mRNA levels in PBMCs following the intake of the three breakfasts may be due 
to that the synthesis and secretion processes of these proteins do not happen 
simultaneously, and to the short half-life of cytokines(Futterman and Lemberg 2002; 
Kishimoto 2005).  
3.3 Endothelial function 
In the last years another interesting observation is that dietary fat may affect the 
endothelium(Berry, et al. 2008; Fuentes, et al. 2008; Goode, et al. 1997), and factors related to 
the arterial wall(Perez-Jimenez, et al. 1999). Several studies have shown that the acute 
administration of a high-fat meal induces a transitory disruption of endothelial function. 
Moreover, the effect of chronic consumption of a high-fat diet on endothelial function has 
also been evaluated. One study showed that a Mediterranean-style diet administered during 
28 days to healthy subjects, attenuated plasma markers of endothelial activation, suggesting 
an improvement in endothelial function(Perez-Jimenez et al. 1999). Similarly, the chronic 
consumption of low-fat diets and Mediterranean-style diets improve endothelial function 
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compared to a high-fat Western-type diet in hypercholesterolemic patients(Fuentes, et al. 
2001). In this line, Esposito et al. demonstrated that the consumption of a Mediterranean-
style diet by patients with the MetS was associated with improvement of endothelial 
function, by assessing the vascular responses to L-arginine, the natural precursor of nitric 
oxide(Esposito et al. 2004). More recently Radillis et al. observed that the close adherence to 
a MedDiet diet improves endothelial function in subjects with abdominal obesity(Rallidis, et 
al. 2009). On the other hand, previous studies also demonstrated that postprandial lipemia 
induces endothelial dysfunction(Anderson, et al. 2001; Bae, et al. 2003). According to this 
fact, Fuentes et al. studied the chronic effect of three diets with different fat compositions 
(high-SFA; high-MUFA; and a low-fat diet enriched in alpha-linolenic acid) on postprandial 
endothelial function and inflammatory biomarkers in twenty healthy men. This study 
demonstrated that the endothelium-dependent vasodilatory response was greater after the 
ingestion of the high-MUFA diet. Moreover this diet also induced lower postprandial 
sVCAM-1 levels and higher bioavailability of NOx compared with the other two 
diets(Fuentes et al. 2008). In the same line, Perez-Martinez et al. have recently showed that a 
high-MUFA diet improves endothelial cell, improving vasomotor function, with a higher 
availability of nitric oxide synthase and decreasing plasma sICAM-1 levels compared with a 
high-SFA diet and two low-fat, high complex carbohydrate diets, supplemented with 1.24 
g/day of long chain n-3 PUFA or placebo, in MetS patients(Perez-Martinez, et al. 2010b). 
Therefore, those data carried out in the postprandial state support previous evidences 
suggesting that dietary patterns similar to those of the Mediterranean-style diet exert 
positive effects on components of the MetS and other conditions associated with, including 
endothelial dysfunction(Esposito, et al. 2006; Esposito et al. 2004). In the same population, 
the high-MUFA diet improved postprandial oxidative stress parameters as measured by 
glutathione levels and the glutathione/oxidized glutathione ratio. In addition, this diet 
induced lower postprandial plasma levels of lipoperoxides, protein carbonyls concentration 
and superoxide dismutase activity compared to subjects adhering to the other three 
diets(Perez-Martinez, et al. 2010a). Furthermore, postprandial plasma hydrogen peroxide 
levels were unfavourable increased during the high-SFA diet compared to the other three 
diets(Perez-Martinez et al. 2010a). These findings suggest that the postprandial state is 
important for understanding possible cardio-protective effects associated with the MedDiet 
particularly in subject with the MetS. In addition, these findings support recommendations 
to consume a high MUFA diet as a useful tool to prevent cardiovascular diseases in MetS 
patients.  
3.4 Coagulation 
Both endothelial cells and macrophages contribute to the generation of altered 
vasoreactivity and a procoagulant state through increased expression of plasminogen 
activator inhibitor (PAI)-1 and tissue factor and through platelet activation and acute phase 
reactions that increase levels of coagulation factors such as fibrinogen and factor VIII. Many 
of these molecules enter the circulation at levels that correlate with the degree of 
inflammatory activity. It has been well stablished that consumption of MedDiet as a dietary 
pattern, and virgin olive oil as it main fat source, is accompanied by a decrease in 
thrombogenesis, combining a decrease in coagulation factors and by platelet aggregation 
(Delgado-Lista, et al. 2008; Lopez-Miranda et al. 2007; Cicerale, et al. 2009; De La Cruz, et al. 
2010; Gonzalez-Correa, et al. 2008; Lopez-Miranda et al. 2010; Perez-Jimenez et al. 2006; 
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Rasmussen, et al. 1994; Thomsen, et al. 1995; Tripoli, et al. 2005; Visioli, et al. 2005). To infer 
the great value that these facts may have on diabetes, we should have in mind that 
cardiovascular events are the primary cause of death in these patients, and that, a lowering 
in their procoagulant/prothrombotic status is, nowadays, the main prophylactic and 
therapeuthic weapon to avoid cardiovascular events. In other words, adhering to MedDiet 
may act as a prophylaxis for the appearance of thrombotic driven cardiovascular events. 
Reinforcing this hypothesis, some authors have recently published in vitro and animal 
studies in which they show antiaggregant properties of virgin olive oil comparable in 
efficacy to those of acetylsalicylic acid (ASA). Even more, virgin olive oil and ASA, when in 
combination, act synergically to further inhibit platelet activation and aggregation(6, 10). 
Although the cited studies have been realized mostly in healthy persons, diabetic persons 
may also benefit from the antithrombogenic effects of MedDiet. As an example, Rasmussen 
et al showed how non-insulin dependent diabetic patients who were fed a MUFA-rich diet 
for three weeks decreased their von Willebrand factor (an important procoagulant factor) 
when compared to a carbohydrate-rich diet. The same authors, in an elegant design, 
compared the effects of two diets similar in carbohydrate and protein content, one rich in 
MUFA (30 energy %) and one rich in polyunsaturated fatty acids (PUFA) (30 energy %). 
After three weeks, the diet rich in MUFA reduced the levels of von Willebrand factor, 
confirming the results of their previous study, and stating the favourable effect that MUFA 
have on this prothrombotic molecule. 
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Fig. 2. Effects of Mediterranean diet on key features and organs affected by diabetes 
mellitus. MedDiet: Mediterranean diet. DM: diabetes mellitus. SFA: saturated fatty acid. 
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3.5 Nutrigenomics 
It has been recently demonstrated the effects that phenolic fraction of olive oil exert at 
transcriptional level in vivo. In this regard, Camargo et al.(Camargo, et al. 2010) studied 
postprandial gene expression on peripheral blood mononuclear cells. To this end, two virgin 
olive oil-based breakfasts with high and low content of phenolic compounds were 
administered to 20 MetS patients following a double blinded, randomized, crossover design. 
They demonstrated that intake of virgin olive oil rich in phenol compounds is able to 
repress in vivo expression of several pro-inflammatory genes, thereby switching activity of 
peripheral blood mononuclear cells to a less deleterious inflammatory profile. In the same 
context, the consumption of a MedDiet with virgin olive oil,  rich in polyphenols, decreased 
plasma oxidative and inflammatory status and the gene expression related with both 
inflammation (INF-gamma, Rho GTPase-activating protein15, and interleukin-7 receptor) 
and oxidative stress (adrenergic beta(2)-receptor) in PBMCs from healthy 
volunteers(Konstantinidou, et al. 2010). Moreover the same authors demonstrated the 
hypothesis that 3 weeks of nutritional intervention with virgin olive oil supplementation, at 
doses common in the MedDiet, can alter the expression of genes related to atherosclerosis 
development and progression(Khymenets, et al. 2009). In the same line, Llorente-Cortés et 
al.(Llorente-Cortes, et al. 2010) have confirmed in a population at high cardiovascular risk, 
that the MedDiet rich in olive oil influences expression of key genes involved in vascular 
inflammation, thrombosis and, in general, on atherosclerosis susceptibility. Moreover, it has 
been previously demonstrated in mice that olive oil up-regulates uncoupling protein (UCP) 
genes in brown adipose tissue and skeletal muscle(Rodriguez, et al. 2002), which is 
important given that UCP have been related with the regulation of body fat in mammals 
across its participation on the system of thermogenesis(Cypess, et al. 2009). It is well 
reported that mitochondrial biogenesis could, in part, underlie the central role of adipose 
tissue in the control of whole-body metabolism and the actions of some insulin sensitizers 
and that mitochondrial dysfunction might be an important contributing the symptoms of 
MetS(Wilson-Fritch, et al. 2004). In a recent study Hao et al. observed that the 
hydroxytyrosol (HT) treatment resulted in an enhancement of mitochondrial function, 
including an increase in activity and protein expression of mitochondrial complexes I, II, III 
and V; increased oxygen consumption; and a decrease in free fatty acid contents in the 
adipocytes. These data suggest that HT is able to promote mitochondrial function by 
stimulating mitochondrial biogenesis. This mitochondrial targeting property may provide a 
possible mechanism for the efficacy of the MedDiet for lowering the risk of cardiovascular 
disease and also suggests that HT may be used as a therapeutic intervention for preventing 
and treating diabetes mellitus and obesity(Hao, et al. 2010).  
4. Summary and future direction 
Because unhealthy eating habits and a sedentary lifestyle are among the strongest risk 
factors for metabolic syndrome and type 2 diabetes, modification of eating habits and 
physical activity constitutes an important component of any successful management 
program. In this chapter we reviewed the state of the art illustrating the relationship 
between MedDiet rich in olive oil and metabolic diseases, and to discuss potential 
mechanisms by which this food can help in disease prevention and treatment. 
Epidemiological and intervention studies indicate that MedDiet, thanks to its set of benefits, 
may protect from metabolic diseases that are related to chronic inflammation and 
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overproduction of reactive oxygen species, such as MetS and diabetes. However, despite the 
significant advances of the last years, the final proof about the specific mechanisms and 
contributing role of the different dietary models and nutrients to its beneficial effects 
requires further investigations. In the future, the integrated application of approaches that 
are becoming available in functional genomics, metabonomics, lipidomics, microbiota, 
cronobiology, proteomic techniques, and bioinformatics analysis, will lead to a more highly 
integrated understanding of its positive effects on health. In this context the recent advances 
in human nutrigenomics and nutrigenetics, two fields with distinct approaches to elucidate 
the interaction between diet and genes but with a common ultimate goal to optimize health 
through the personalization of diet, will provide powerful approaches to unravel the 
complex relationship between nutritional molecules, genetic polymorphisms, and the 
biological system as a whole. On the other hand efforts should be put into identifying those 
micronutrients in olive oil that have the greatest beneficial effects on health.  
In conclusion after decades of epidemiological, clinical and experimental research, it has 
become clear that consumption of Mediterranean dietary patterns rich in olive oil have a 
profound influence on health outcomes. Thus, there is good scientific support for 
recommend MedDiets, especially those based on olive oil, as an alternative approach for the 
medical nutritional therapy in obesity, MetS and diabetes. 
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